1-propanol has been researched along with Parkinson Disease in 15 studies
1-Propanol: A colorless liquid made by oxidation of aliphatic hydrocarbons that is used as a solvent and chemical intermediate.
propan-1-ol : The parent member of the class of propan-1-ols that is propane in which a hydrogen of one of the methyl groups is replaced by a hydroxy group.
Parkinson Disease: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (86.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (6.67) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Ma, C | 1 |
| Feng, Y | 1 |
| Li, X | 1 |
| Sun, L | 1 |
| He, Z | 1 |
| Gan, J | 1 |
| He, M | 1 |
| Zhang, X | 1 |
| Chen, X | 1 |
| DESCHAUER, A | 1 |
| SCHWARZ, D | 1 |
| SIEBENHAAR, C | 1 |
| LIENAU, C | 1 |
| Jurna, I | 1 |
| Oelszner, W | 1 |
| Walther, H | 1 |
| Wagner, U | 1 |
| Krieger, H | 1 |
| Jackson, R | 1 |
| Crawford, CO | 1 |
| Peel, JS | 1 |
| Nakano, KK | 1 |
| Zubick, H | 1 |
| Tyler, HR | 2 |
| Simpson, GM | 1 |
| Timberlake, WH | 2 |
| McLennan, JE | 1 |
| Nakano, K | 1 |
| Schwab, RS | 1 |
| Haumonté, MT | 1 |
| Lefèvre, E | 1 |
1 review available for 1-propanol and Parkinson Disease
| Article | Year |
|---|---|
[Drug research on norbornan derivatives. 2].
Topics: 1-Propanol; Acids; Alcohols; Amines; Amino Alcohols; Analgesics; Anesthetics, Local; Animals; Anti-I | 1968 |
5 trials available for 1-propanol and Parkinson Disease
| Article | Year |
|---|---|
Oxprenolol in Parkinson's disease.
Topics: 1-Propanol; Adrenergic beta-Antagonists; Aged; Amino Alcohols; Clinical Trials as Topic; Euphoria; F | 1971 |
Speech defects of parkinsonian patients. Effects of levodopa therapy on speech intelligibility.
Topics: 1-Propanol; Adult; Aged; Antiparkinson Agents; Dihydroxyphenylalanine; Evaluation Studies as Topic; | 1973 |
Controlled studies of antiparkinsonism agents in the treatment of drug-induced extrapyramidal sympttoms.
Topics: 1-Propanol; Adult; Biperiden; Clinical Trials as Topic; Handwriting; Humans; Male; Middle Aged; Neur | 1970 |
Double-blind comparison of levodopa and procyclidine in parkinsonism, with illustrations of levodopa-induced movement disorders.
Topics: 1-Propanol; Adult; Clinical Trials as Topic; Dihydroxyphenylalanine; Female; Humans; Male; Middle Ag | 1970 |
Double-blind comparison of levodopa and procyclidine in parkinsonism, with illustrations of levodopa-induced movement disorders.
Topics: 1-Propanol; Adult; Aged; Clinical Trials as Topic; Dihydroxyphenylalanine; Female; Humans; Male; Mid | 1970 |
9 other studies available for 1-propanol and Parkinson Disease
| Article | Year |
|---|---|
Potential Therapeutic Effects of Policosanol from Insect Wax on Caenorhabditis elegans Models of Parkinson's Disease.
Topics: alpha-Synuclein; Animals; Animals, Genetically Modified; Caenorhabditis elegans; Disease Models, Ani | 2023 |
Essential tremor and how to manage it. This condition is less well known than Parkinson's disease, but it's far more common.
Topics: 1-Propanol; Activities of Daily Living; Diagnosis, Differential; Essential Tremor; Health Behavior; | 2010 |
[Experiences in the treatment of parkinsonism with KL 373 in combination with soventolette].
Topics: 1-Propanol; Ethanol; Humans; Parkinson Disease; Parkinsonian Disorders | 1955 |
[A new medical treatment of parkinsonism].
Topics: 1-Propanol; Alcohols; Histamine H1 Antagonists; Humans; Parkinson Disease; Parkinsonian Disorders | 1955 |
[New methods in management of parkinsonism].
Topics: 1-Propanol; Disease Management; Ethanol; Parkinson Disease; Parkinsonian Disorders | 1956 |
Reserpine rigidity in the rat--a model for the analysis of antiparkinson drugs.
Topics: 1-Propanol; Animals; Biperiden; Cerebral Decortication; Electromyography; Methamphetamine; Models, N | 1968 |
[Experimental testing of some piperidine propanol diastereomers in animals as potential parkinsonism drugs].
Topics: 1-Propanol; Animals; Central Nervous System; Ileum; Mice; Organ Culture Techniques; Parasympatholyti | 1971 |
Micrographia in Parkinson's disease.
Topics: 1-Propanol; Dihydroxyphenylalanine; Female; Handwriting; Humans; Male; Neurologic Manifestations; Pa | 1972 |
[Clinical study of a synthetic anti-parkinsonian drug, akinophyl (or 2-piperidino-1-phenyl-bicycloheptenyl-propanol chlorhydrate)].
Topics: 1-Propanol; Adult; Age Factors; Aged; Bipolar Disorder; Follow-Up Studies; Humans; Middle Aged; Neur | 1969 |